Identifying Patients Who are Ideal Candidates for Nanoliposomal Topoisomerase Inhibitors in Metastatic Pancreatic Adenocarcinoma:

Identifying Patients Who are Ideal Candidates for Nanoliposomal Topoisomerase Inhibitors in Metastatic Pancreatic Adenocarcinoma:


Published

Created by

CMEducation Resources symposium

Related Presenters

Kenneth Yu, MD, MSc

Kenneth Yu, MD, MSc

Program Co-Chair
Assistant Professor of Medicine
Gastrointestinal Oncology Service
Memorial Sloan Kettering Cancer Center
New York, NY